Endocrine Disruptors

Paul Smaglik and the four scientists he quotes in the Sept. 14 issue (P. Smaglik, The Scientist, 12[18]:1, Sept. 14, 1998) appear quite convinced that there are some, possibly many, chemicals in the environment that are "endocrine disruptors" and cause various adverse effects. They seem concerned only that the EPA program may not find all of these harmful products or mixtures. Many of the scientists I know agree that DES causes significant pathology as an "endocrine disruptor," and exposur

Written byWalter Newman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Paul Smaglik and the four scientists he quotes in the Sept. 14 issue (P. Smaglik, The Scientist, 12[18]:1, Sept. 14, 1998) appear quite convinced that there are some, possibly many, chemicals in the environment that are "endocrine disruptors" and cause various adverse effects. They seem concerned only that the EPA program may not find all of these harmful products or mixtures.

Many of the scientists I know agree that

There appears to be little evidence that small amounts of chemicals have caused or can cause adverse effects to humans or other living organisms by "estrogen disruption." This is truly a case of Congress mandating specific studies, spending much money, brain power, effort, and test animals before knowing if a problem exists or, if one exists, its magnitude and causes.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies